Literature DB >> 6421934

Use of a zwitterionic detergent for the restoration of the antibody-binding capacity of electroblotted meningococcal outer membrane proteins.

R E Mandrell, W D Zollinger.   

Abstract

A method is described for the partial restoration of the antibody-binding capacity of meningococcal class 2 outer membrane proteins (40-42 K molecular weight) following denaturation (dissociation) in boiling sodium dodecyl sulfate (SDS). The method relies on the presence of 0.1-0.4% zwitterionic detergent in the electrode buffer during the electroblot transfer of proteins from SDS-polyacrylamide gels to nitrocellulose paper. Meningococcal class 2 proteins which had lost their earlier capacity to bind mouse monoclonal antibodies in the normal blot procedure after SDS-polyacrylamide gel electrophoresis, bound monoclonal antibodies following the addition of the zwitterionic detergent to the blot buffer. Human post-vaccination anti-class 2 protein antibodies reacted with serotype 2a class 2 protein in a similar manner. This simple modification to the electroblot procedure proved helpful in identifying mouse monoclonal antibodies and human antibodies specific for native meningococcal class 2 proteins.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6421934     DOI: 10.1016/0022-1759(84)90080-2

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  27 in total

1.  Restriction-site-specific PCR as a rapid test to detect enterohemorrhagic Escherichia coli O157:H7 strains in environmental samples.

Authors:  R Kimura; R E Mandrell; J C Galland; D Hyatt; L W Riley
Journal:  Appl Environ Microbiol       Date:  2000-06       Impact factor: 4.792

2.  Analysis of human hepatic microsomal glucose-6-phosphatase in clinical conditions where the T2 pyrophosphate/phosphate transport protein is absent.

Authors:  R C Nordlie; H M Scott; I D Waddell; R Hume; A Burchell
Journal:  Biochem J       Date:  1992-02-01       Impact factor: 3.857

3.  Variation in expression of class 1 and class 5 outer membrane proteins during nasopharyngeal carriage of Neisseria meningitidis.

Authors:  J P Woods; J G Cannon
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

4.  Functional and specific antibody responses in adult volunteers in new zealand who were given one of two different meningococcal serogroup B outer membrane vesicle vaccines.

Authors:  E Wedege; K Bolstad; A Aase; T K Herstad; L McCallum; E Rosenqvist; P Oster; D Martin
Journal:  Clin Vaccine Immunol       Date:  2007-05-09

5.  Identification and characterization of a hepatic microsomal glucose transport protein. T3 of the glucose-6-phosphatase system?

Authors:  I D Waddell; H Scott; A Grant; A Burchell
Journal:  Biochem J       Date:  1991-04-15       Impact factor: 3.857

6.  Monoclonal antibodies reveal structural homogeneity of gamma-aminobutyric acid/benzodiazepine receptors in different brain areas.

Authors:  P Häring; C Stähli; P Schoch; B Takács; T Staehelin; H Möhler
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

7.  Recombination near the antibiotic resistance locus penB results in antigenic variation of gonococcal outer membrane protein I.

Authors:  D Danielsson; H Faruki; D Dyer; P F Sparling
Journal:  Infect Immun       Date:  1986-05       Impact factor: 3.441

8.  Evaluation of Diverse Antisera, Conjugates, and Support Media for Detecting Bradyrhizobium japonicum by Indirect Enzyme-Linked Immunosorbent Assay.

Authors:  A Ayanaba; K D Weiland; R M Zablotowicz
Journal:  Appl Environ Microbiol       Date:  1986-11       Impact factor: 4.792

9.  Immune responses against major outer membrane antigens of Neisseria meningitidis in vaccinees and controls who contracted meningococcal disease during the Norwegian serogroup B protection trial.

Authors:  E Wedege; E A Høiby; E Rosenqvist; G Bjune
Journal:  Infect Immun       Date:  1998-07       Impact factor: 3.441

10.  Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine.

Authors:  E Rosenqvist; E A Høiby; E Wedege; K Bryn; J Kolberg; A Klem; E Rønnild; G Bjune; H Nøkleby
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.